LadRx Corporation – OTC:CYTR

LadRx stock price today

$0.092

LadRx stock price monthly change

-2.06%
month

LadRx stock price quarterly change

-10.77%
quarter

LadRx stock price yearly change

-82.64%
year

LadRx key metrics

Market Cap
 N/A
Enterprise value
 199.29K
P/E
 -0.25
EV/Sales
 N/A
EV/EBITDA
 -0.01
Price/Sales
 N/A
Price/Book
 1.74
PEG ratio
 N/A
EPS
 -130.95
Revenue
 N/A
EBITDA
 -7.67B
Income
 -3.62B
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

LadRx stock price history

LadRx stock forecast

LadRx financial statements

Profit Margin

LadRx Corporation (OTC:CYTR): Profit margin
Dec 2022 0 -4.75B
Mar 2023 0 -1.20B
Jun 2023 0 3.14B
Sep 2023 0 -815.98M
CYTR income statement history

Debt to Assets

LadRx Corporation (OTC:CYTR): Debt to assets
Dec 2022 2246772000 2.22B 98.86%
Mar 2023 1230438000 3.65B 297.16%
Jun 2023 3982285000 2.20B 55.27%
Sep 2023 3065566000 2.10B 68.51%
CYTR balance sheet history

Cash Flow

LadRx Corporation (OTC:CYTR): Cash Flow
Dec 2022 -4.82B -758.23K -560.80M
Mar 2023 -699.81M 0 -68.80M
Jun 2023 3K 0 0
Sep 2023 0 0 0
CYTR cash flow history

LadRx alternative data

LadRx
Employees

LadRx Corporation (OTC:CYTR): Employee count
Aug 2023 3
Sep 2023 3
Oct 2023 3
Nov 2023 3
Dec 2023 3
Jan 2024 3
Feb 2024 3
Mar 2024 3
Apr 2024 3
May 2024 3
Jun 2024 3
Jul 2024 3

LadRx other data

LadRx
Insider Trading

LadRx Corporation (OTC:CYTR): Insider trades (number of shares)
Period Buy Sel
Mar 2013 94860 0
Apr 2013 4083 0
Nov 2013 215700 0
Dec 2013 454258 0
Transaction Date Insider Security Shares Price per share Total value Source
Option
BRIEN EARL W director
 Common Stock, par value $0.001 per share 150,000 $0.26 $39,000
Option
BRIEN EARL W director
 Stock Option (right to buy) 150,000 $0.26 $39,000
Option
CALDWELL JOEL K director
 Common Stock, par value $0.001 per share 450,000 $0.26 $117,000
Option
CALDWELL JOEL K director
 Stock Option (right to buy) 450,000 $0.26 $117,000
Option
IGNARRO LOUIS director
 Common Stock, par value $0.001 per share 700,000 $0.26 $182,000
Option
IGNARRO LOUIS director
 Stock Option (right to buy) 700,000 $0.26 $182,000
Option
KRIEGSMAN STEVEN A director, officer.. Common Stock, par value $0.001 per share 3,000,000 $0.26 $780,000
Option
KRIEGSMAN STEVEN A director, officer.. Stock Option (right to buy) 3,000,000 $0.26 $780,000
Purchase
PATTERSON SCOTT BRADFORD 10 percent owner
 CYTR Common Stock, $0.01 par value per share 334,979 $2.4 $805,290
Purchase
PATTERSON SCOTT BRADFORD 10 percent owner
 CYTR Common Stock, $0.01 par value per share 42,131 $2.35 $98,924
CYTR insider trading transactions

LadRx
Patents

Patent
Application
Filling date: 19 Feb 2019 Issue date: 21 Nov 2019
CYTR patents

Frequently Asked Questions (FAQ)

  • What's the price of LadRx stock today?

    One share of LadRx stock can currently be purchased for approximately $0.09.

  • When is LadRx's next earnings date?

    Unfortunately, LadRx's (CYTR) next earnings date is currently unknown.

  • Does LadRx pay dividends?

    No, LadRx does not pay dividends.

  • What is LadRx's stock symbol?

    LadRx Corporation is traded on the OTC under the ticker symbol "CYTR".

  • What is LadRx's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of LadRx?

    Shares of LadRx can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are LadRx's key executives?

    LadRx's management team includes the following people:

    • Mr. Steven A. Kriegsman Chief Executive Officer(age: 83, pay: $1,010,000)
    • Mr. John Y. Caloz Chief Financial Officer, Treasurer & Senior Vice President(age: 73, pay: $500,000)

  • How many employees does LadRx have?

    As Jul 2024, LadRx employs 3 workers.

  • When LadRx went public?

    LadRx Corporation is publicly traded company for more then 38 years since IPO on 10 Nov 1986.

  • What is LadRx's official website?

    The official website for LadRx is cytrx.com.

  • Where are LadRx's headquarters?

    LadRx is headquartered at 11726 San Vicente Blvd Ste 650, Los Angeles, CALIFORNIA.

  • How can i contact LadRx?

    LadRx's mailing address is 11726 San Vicente Blvd Ste 650, Los Angeles, CALIFORNIA and company can be reached via phone at +1 310 826 5648.

LadRx company profile:

LadRx Corporation

cytrx.com
Exchange:

OTC

Full time employees:

3

Industry:

Biotechnology

Sector:

Healthcare

LadRx Corporation, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat patients with cancer. The company's advanced drug conjugate, aldoxorubicin that is in late-stage clinical trials is a version of anti-cancer drug doxorubicin. Its pre-clinical therapeutics comprise linker activated drug releases 7, 8, 9, and 10 targeted against cancer The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. LadRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California.

+1 310 826 5648
11726 San Vicente Blvd Ste 650
Los Angeles, CALIFORNIA 90049

CIK: 0000799698
ISIN: US2328286081
CUSIP: 232828608